Literature DB >> 33582241

Distinct effects of chondroitin sulfate on hematopoietic cells and the stromal microenvironment in bone marrow hematopoiesis.

Takayuki Katagiri1, Shun Uemura2, Takashi Ushiki1, Yaeko Nakajima-Takagi3, Motohiko Oshima3, Tadahisa Mikami4, Asami Kawasaki5, Hajime Ishiguro1, Tomoyuki Tanaka1, Hirohito Sone1, Hiroshi Kitagawa4, Michihiro Igarashi5, Atsushi Iwama3, Masayoshi Masuko6.   

Abstract

The bone marrow (BM) microenvironment, known as the BM niche, regulates hematopoiesis but is also affected by interactions with hematopoietic cells. Recent evidence indicates that extracellular matrix components are involved in these interactions. Chondroitin sulfate (CS), a glycosaminoglycan, is a major component of the extracellular matrix; however, it is not known whether CS has a physiological role in hematopoiesis. Here, we analyzed the functions of CS in hematopoietic and niche cells. CSGalNAcT1, which encodes CS N-acetylgalactosaminyltransferase-1 (T1), a key enzyme in CS biosynthesis, was highly expressed in hematopoietic stem and progenitor cells (HSPCs) and endothelial cells (ECs), but not in mesenchymal stromal cells (MSCs) in BM. In T1 knockout (T1KO) mice, a greater number of HSPCs existed compared with the wild-type (WT), but HSPCs from T1KO mice showed significantly impaired repopulation in WT recipient mice on serial transplantation. RNA sequence analysis revealed the activation of IFN-α/β signaling and endoplasmic reticulum stress in T1KO HSPCs. In contrast, the number of WT HSPCs repopulated in T1KO recipient mice was larger than that in WT recipient mice after serial transplantation, indicating that the T1KO niche supports repopulation of HSPCs better than the WT niche. There was no obvious difference in the distribution of vasculature and MSCs between WT and T1KO BM, suggesting that CS loss alters vascular niche functions without affecting its structure. Our results revealed distinct roles of CS in hematopoietic cells and BM niche, indicating that crosstalk between these components is important to maintain homeostasis in BM.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Year:  2021        PMID: 33582241     DOI: 10.1016/j.exphem.2021.02.003

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

1.  CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk.

Authors:  Yi Chen; Yang Zhang; Zhihua Wang; Yewei Wang; Yujiao Luo; Nannan Sun; Shasha Zheng; Wenzhe Yan; Xiang Xiao; Sufang Liu; Ji Li; Hongling Peng; Yunxiao Xu; Guoyu Hu; Zhao Cheng; Guangsen Zhang
Journal:  Cell Death Dis       Date:  2022-07-07       Impact factor: 9.685

2.  Characterization of chondroitin sulfate in stem cells derived from umbilical cord blood in rats.

Authors:  Keiko Nakanishi; Kyohei Higashi; Toshihiko Toida; Masato Asai
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.240

3.  Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic Syndromes.

Authors:  Amanpreet Kaur Bains; Lena Behrens Wu; Jennifer Rivière; Sandra Rother; Valentina Magno; Jens Friedrichs; Carsten Werner; Martin Bornhäuser; Katharina S Götze; Michael Cross; Uwe Platzbecker; Manja Wobus
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

4.  Characterisation of canine CD34+/CD45 diminished cells by colony-forming unit assay and transcriptome analysis.

Authors:  Taro Ayabe; Masaharu Hisasue; Yoko Yamada; Suguru Nitta; Kaoruko Kikuchi; Sakurako Neo; Yuki Matsumoto; Ryo Horie; Kosuke Kawamoto
Journal:  Front Vet Sci       Date:  2022-09-12

5.  Transcriptomics of Wet Skin Biopsies Predict Early Radiation-Induced Hematological Damage in a Mouse Model.

Authors:  Abdulnaser Alkhalil; John Clifford; Stacy Ann Miller; Aarti Gautam; Marti Jett; Rasha Hammamieh; Lauren T Moffatt; Jeffrey W Shupp
Journal:  Genes (Basel)       Date:  2022-03-18       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.